- Markets
- Chemicals
- ARCHITORG
ARCHITORG
New to Zerodha? Sign-up for free.
New to Zerodha? Sign-up for free.
-
Share Price
-
Financials
-
Revenue mix
-
Shareholdings
-
Peers
-
Forensics
- 5D
- 1M
- 6M
- YTD
- 1Y
- 5Y
- MAX
This data is currently unavailable for this company.
-
Summary
-
Profit & Loss
-
Balance sheet
-
Cashflow
This data is currently unavailable for this company.
(In Cr.) |
---|
(In Cr.) | ||||
---|---|---|---|---|
This data is currently unavailable for this company. |
(In %) |
---|
(In Cr.) |
---|
Financial Year (In Cr.) |
---|
-
Product wise
-
Location wise
Revenue Mix
This data is currently unavailable for this company.
Revenue Mix
This data is currently unavailable for this company.
Recent events
-
News
-
Corporate Actions
Archit Organosys CFO Ajay P Patel Resigns
Feb 26 (Reuters) - Archit Organosys Ltd ARCI.BO:
ARCHIT ORGANOSYS LTD - AJAY P PATEL RESIGNS AS CFO
Source text: ID:nBSE96KhHf
Further company coverage: ARCI.BO
(([email protected];;))
Feb 26 (Reuters) - Archit Organosys Ltd ARCI.BO:
ARCHIT ORGANOSYS LTD - AJAY P PATEL RESIGNS AS CFO
Source text: ID:nBSE96KhHf
Further company coverage: ARCI.BO
(([email protected];;))
Archit Organosys Approves Disinvestment Of Entire 50.01% Stake In Unit
March 27 (Reuters) - Archit Organosys Ltd ARCI.BO:
APPROVED DISINVESTMENT OF ENTIRE 50.01% STAKE IN UNIT NOVEL AND NANO XTREME SOLUTIONS LLP
Source text for Eikon: ID:nBSE5rj9r1
Further company coverage: ARCI.BO
(([email protected];))
March 27 (Reuters) - Archit Organosys Ltd ARCI.BO:
APPROVED DISINVESTMENT OF ENTIRE 50.01% STAKE IN UNIT NOVEL AND NANO XTREME SOLUTIONS LLP
Source text for Eikon: ID:nBSE5rj9r1
Further company coverage: ARCI.BO
(([email protected];))
Archit Organosys Says HDFC Bank Has Agreed Entering Into One Time Settlement
March 5 (Reuters) - Archit Organosys Ltd ARCI.BO:
ARCHIT ORGANOSYS LTD - HDFC BANK HAS AGREED ENTERING INTO ONE TIME SETTLEMENT FOR FULL AND FINAL AMICABLE SETTLEMENT
ARCHIT ORGANOSYS LTD - HDFC HAS AGREED FOR CONSOLIDATED AMOUNT OF 25 MILLION RUPEES
Source text for Eikon: ID:nBSE6Mxgg5
Further company coverage: ARCI.BO
(([email protected];))
March 5 (Reuters) - Archit Organosys Ltd ARCI.BO:
ARCHIT ORGANOSYS LTD - HDFC BANK HAS AGREED ENTERING INTO ONE TIME SETTLEMENT FOR FULL AND FINAL AMICABLE SETTLEMENT
ARCHIT ORGANOSYS LTD - HDFC HAS AGREED FOR CONSOLIDATED AMOUNT OF 25 MILLION RUPEES
Source text for Eikon: ID:nBSE6Mxgg5
Further company coverage: ARCI.BO
(([email protected];))
Archit Organosys Says Subscribed To Right Issue Of Archit Life Science
Jan 30 (Reuters) - Archit Organosys Ltd ARCI.BO:
SUBSCRIBED TO RIGHT ISSUE OF ARCHIT LIFE SCIENCE
COST OF ACQUISITION 29.5 MILLION RUPEES
Source text for Eikon: ID:nBSE6fMtV6
Further company coverage: ARCI.BO
(([email protected];))
Jan 30 (Reuters) - Archit Organosys Ltd ARCI.BO:
SUBSCRIBED TO RIGHT ISSUE OF ARCHIT LIFE SCIENCE
COST OF ACQUISITION 29.5 MILLION RUPEES
Source text for Eikon: ID:nBSE6fMtV6
Further company coverage: ARCI.BO
(([email protected];))
Events:
Dividend
Dividend
Dividend
Rights
More Micro Cap Ideas
See similar 'Micro' cap companies with recent activity
Promoter Buying
Companies where the promoters are bullish
Capex
Companies investing on expansion
Superstar Investor
Companies where well known investors have invested
Popular questions
-
Business
-
Financials
-
Share Price
-
Shareholdings
What does Archit Organosys do?
Shri Chlochem Ltd is a key player in chemical manufacturing and exports, offering products like Monochloro Acetic Acid (MCA), Sodium Monochloro Acetate (SMCA), Pigment, and Shade Card.
Who are the competitors of Archit Organosys?
Archit Organosys major competitors are Resonance Specialtie, Alkali Metals, Par Drugs & Chem., Sanginita Chemicals, Polson, Rite Zone Chemcon, IVP. Market Cap of Archit Organosys is ₹86 Crs. While the median market cap of its peers are ₹93 Crs.
Is Archit Organosys financially stable compared to its competitors?
Archit Organosys seems to be less financially stable compared to its competitors. Altman Z score of Archit Organosys is 2.78 and is ranked 7 out of its 8 competitors.
Does Archit Organosys pay decent dividends?
The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. Archit Organosys latest dividend payout ratio is 9.04% and 3yr average dividend payout ratio is 13.87%
How has Archit Organosys allocated its funds?
Companies resources are majorly tied in miscellaneous assets
How strong is Archit Organosys balance sheet?
Balance sheet of Archit Organosys is moderately strong.
Is the profitablity of Archit Organosys improving?
The profit is oscillating. The profit of Archit Organosys is ₹3.28 Crs for Mar 2024, ₹11.35 Crs for Mar 2023 and ₹8.23 Crs for Mar 2022
Is the debt of Archit Organosys increasing or decreasing?
The debt of Archit Organosys is decreasing. Latest debt of Archit Organosys is ₹20.7 Crs as of Mar-24. This is less than Mar-23 when it was ₹25.19 Crs.
Is Archit Organosys stock expensive?
Yes, Archit Organosys is expensive. Latest PE of Archit Organosys is 26.22, while 3 year average PE is 17.86. Also latest EV/EBITDA of Archit Organosys is 12.15 while 3yr average is 10.01.
Has the share price of Archit Organosys grown faster than its competition?
Archit Organosys has given lower returns compared to its competitors. Archit Organosys has grown at ~-21.66% over the last 2yrs while peers have grown at a median rate of -5.81%
Is the promoter bullish about Archit Organosys?
Promoters seem to be bullish about the company. Latest quarter promoter holding is 64.84% and last quarter promoter holding is 64.65%.
Are mutual funds buying/selling Archit Organosys?
There is Insufficient data to gauge this.